Received Sep 15, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | 2 | UNK | — |
achiness in neck particularly the left side; muscle tightness; nausea; unsteady stomach; This non-serious case was reported by a consumer via call center representative and described the occurrence of neck pain in a 50-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. Previously administered products included Shingrix with an associated reaction of injection site pain (For tolerance to first dose refer case US2025AMR107941). On 13-AUG-2025, the patient received the 2nd dose of Shingrix. In AUG-2025, less than a week after receiving Shingrix, the patient experienced neck pain (Verbatim: achiness in neck particularly the left side), muscle tightness (Verbatim: muscle tightness), nausea (Verbatim: nausea) and upset stomach (Verbatim: unsteady stomach). The outcome of the neck pain and muscle tightness were not resolved and the outcome of the nausea and upset stomach were not reported. It was unknown if the reporter considered the neck pain, muscle tightness, nausea and upset stomach to be related to Shingrix. It was unknown if the company considered the neck pain, muscle tightness, nausea and upset stomach to be related to Shingrix. Linked case(s) involving the same patient: US2025AMR107941 Additional Information: GSK receipt date: 18-AUG-2025 The patient reported side effects including a bit of nausea and unsteady stomach, along with muscle tightness and achiness in neck, particularly the left side. All of the recommended treatments were used (ice, heat, Ibuprofen and stretching). But the pain was not going away nor the tightness. For tolerance to first dose refer case US2025AMR107941.; Sender's Comments: US-GSK-US2025AMR107941:same patient first dose